Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Primary ciliary dyskinesia

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

PCD can be complicated by severe infective exacerbation, sepsis, respiratory failure, major haemoptysis or pneumothorax. Stabilise according to the presenting emergency, obtain sputum before antibiotics when this does not delay care, involve the specialist respiratory team and use previous cultures and resistance data. Situs inversus changes the position of examination, ECG and procedural landmarks; verify anatomy rather than assuming standard organ location.

Synopsis

Identify the lifelong respiratory and laterality pattern of primary ciliary dyskinesia, refer for a multi-test specialist diagnosis, and coordinate airway, ear, fertility and transition care without falsely excluding disease after one normal test.

  • PCD is a genetically heterogeneous disorder of motile cilia causing impaired mucociliary clearance, chronic upper and lower airway infection, and sometimes abnormal left-right organ arrangement.
  • A daily wet cough from early infancy, persistent rhinitis, recurrent otitis media and unexplained neonatal respiratory distress in a term baby form a high-value diagnostic pattern.
  • Situs inversus or heterotaxy is a clue rather than a requirement; many affected people have ordinary situs, and heterotaxy can include clinically important congenital heart disease.
  • There is no single universal gold-standard test: diagnosis integrates nasal nitric oxide, ciliary functional and ultrastructural studies, immunofluorescence and genetics in an accredited specialist pathway.
  • Normal transmission electron microscopy does not exclude PCD because several genetic subtypes have apparently normal ultrastructure; genotype and function may resolve these cases.
  • Management centres on regular airway clearance, exercise, surveillance cultures, prompt tailored treatment of exacerbations, vaccination and specialist bronchiectasis care rather than a curative respiratory medicine.
  • Chronic hearing difficulty can affect language, education and work; audiology and ENT input should account for the possibility that ventilation tubes may produce prolonged discharge.
  • Subfertility affects people of any sex through impaired sperm motility or fallopian-tube ciliary function, so reproductive goals and ectopic-pregnancy risk deserve timely, sensitive discussion.

Key red flags

Laterality and cardiac clues

Dextrocardia, complete situs inversus or heterotaxy strengthens suspicion. Heterotaxy can accompany complex cardiac or splenic abnormalities, so anatomy and previous surgical history must be defined accurately.

Escalating suppurative disease

Increasing sputum, breathlessness, haemoptysis, fever or falling oxygen saturation may represent an exacerbation or complication and should be managed promptly using previous airway microbiology.

Investigation priorities

01
Nasal nitric oxideFirst stepFirst line

Provide a sensitive first-line physiological test in an appropriate specialist setting.

Management branches

ReferBuild the diagnostic phenotype

A lifelong wet cough, neonatal respiratory history, laterality anomaly or combined ear, sinus and bronchiectatic disease suggests PCD.

  1. Construct a timeline from birth, including neonatal oxygen, year-round rhinitis and cough, ear disease, situs, congenital heart disease, fertility history and affected relatives.
  2. Exclude common mimics with immune testing, cystic fibrosis assessment and aspiration review as indicated, but send a convincing phenotype to the national diagnostic pathway rather than awaiting every local result.
  3. Let the specialist centre sequence nasal nitric oxide, functional microscopy, ultrastructure, immunofluorescence and genetics, repeating infection-affected samples before declaring the evaluation negative.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • ERS guideline for diagnosis of primary ciliary dyskinesiaSpecialist-society diagnostic framework for referral features, nasal nitric oxide, functional microscopy, ultrastructure and genetics.
  • ATS and ERS guideline for diagnosis of primary ciliary dyskinesiaUpdated international evidence-based diagnostic guidance published in 2025.
  • NHS England adult PCD management service specificationCurrent commissioned English specialist-service model for adult assessment, multidisciplinary management and shared care.
  • BTS guideline for bronchiectasis in adultsUK advice on PCD referral clues, airway-clearance care, microbiology and bronchiectasis complications.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom